Intramuscular fat deposition represents a negative prognostic factor for several myopathies, metabolic diseases and aging. Fibro-adipogenic progenitors (FAPs) are considered as the main source of intramuscular adipocytes, but the mechanisms controlling their adipogenic potential are still not elucidated in humans. The aim of this study was to explore the regulation of human FAP adipogenesis by macrophages. We found that CD140a-expressing FAPs were located close to CD68 positive macrophages in muscles from patients with Duchenne muscular dystrophy (DMD). This strongly suggests a potential interaction between FAPs and macrophages in vivo. Under pathological conditions such as Duchenne muscular dystrophy (DMD) 1,2 , type II diabetes 3,4 , sarcopenia 5 , denervation 6,7 , and chronic disease-induced muscle atrophy 8,9 , intramuscular adipocytes invade skeletal muscles and replace a large proportion of muscle fibers. This adipocyte infiltration leads to a poor quality of muscles and dysfunctional performances 10 . Fatty degeneration was shown to be an accurate measurement of the severity of DMD and a limit for the success of current cell and genetic therapies. Many cells can contribute to ectopic intramuscular adipocyte deposits including myoendothelial cells 11, 12 , pericytes 13 , mesoangioblasts 14, 15 and PW1-expressing cells (PICs) 16, 17 . Recent studies demonstrated that intramuscular adipocytes mainly emanated from a population of fibro-adipogenic progenitors (FAPs) that reside between muscle fibers 18, 19 . Their role in muscle regeneration was in part elucidated in mice. After injury, FAPs proliferate, interact with myoblasts to promote the formation of new muscle fibers 18 , and eventually return to quiescent state or are cleared by apoptosis 20 . With impaired regeneration as in DMD, FAPs expand and differentiate to generate the components of the fibro-fatty tissue 21, 22 . We and others have identified the presence of FAPs in human skeletal muscles by the expression of the specific markers CD140a, CD15 and CD34 [23] [24] [25] [26] . In vitro and in vivo, these progenitors differentiate into adipocytes and myofibroblasts in response to adequate stimuli 27, 28 . While Uezumi et al. reported an inhibition of FAP adipogenesis by myoblasts in mice 19 , the regulation of FAP differentiation during muscle regeneration remains to be elucidated in humans.
Under pathological conditions such as Duchenne muscular dystrophy (DMD) 1, 2 , type II diabetes 3, 4 , sarcopenia 5 , denervation 6, 7 , and chronic disease-induced muscle atrophy 8, 9 , intramuscular adipocytes invade skeletal muscles and replace a large proportion of muscle fibers. This adipocyte infiltration leads to a poor quality of muscles and dysfunctional performances 10 . Fatty degeneration was shown to be an accurate measurement of the severity of DMD and a limit for the success of current cell and genetic therapies. Many cells can contribute to ectopic intramuscular adipocyte deposits including myoendothelial cells 11, 12 , pericytes 13 , mesoangioblasts 14, 15 and PW1-expressing cells (PICs) 16, 17 . Recent studies demonstrated that intramuscular adipocytes mainly emanated from a population of fibro-adipogenic progenitors (FAPs) that reside between muscle fibers 18, 19 . Their role in muscle regeneration was in part elucidated in mice. After injury, FAPs proliferate, interact with myoblasts to promote the formation of new muscle fibers 18 , and eventually return to quiescent state or are cleared by apoptosis 20 . With impaired regeneration as in DMD, FAPs expand and differentiate to generate the components of the fibro-fatty tissue 21, 22 . We and others have identified the presence of FAPs in human skeletal muscles by the expression of the specific markers CD140a, CD15 and CD34 [23] [24] [25] [26] . In vitro and in vivo, these progenitors differentiate into adipocytes and myofibroblasts in response to adequate stimuli 27, 28 . While Uezumi et al. reported an inhibition of FAP adipogenesis by myoblasts in mice 19 , the regulation of FAP differentiation during muscle regeneration remains to be elucidated in humans. Among potential regulators of intramuscular adiposity are macrophages whose depletion alters muscle regeneration 29, 30 . In particular, the ablation of CD11b-positive macrophages in mice affects the fat accumulation in injured muscles 31 . Conditioned medium from murine macrophages inhibits the adipogenic potential of a subpopulation of multipotent muscle stem cells 32 . Moreover, molsidomine, a nitric oxide donating drug, modulator of the macrophage recruitment in damaged muscles, reduces the deposition of both skeletal muscle fat and connective tissues in a mouse model of DMD 22 . Interestingly, an interaction between macrophages and FAPs during mouse muscle regeneration has recently been shown 20 . Indeed, infiltrating inflammatory macrophages directly induce apoptosis of FAPs via tumor necrosis factor α (TNFα) secretion. However, in chronic damage, macrophages expressing high level of tumor growth factor β1 (TGFβ1) prevent the apoptosis of FAPs and induce their fibrogenic potential. Our working hypothesis is that macrophage infiltration affects fat expansion through a paracrine action on adipocyte differentiation of human FAPs.
Macrophages can adopt various functional phenotypes and activation states depending on their environment 33 . Very schematically, at least two populations of macrophages have been described according to their inflammatory status. While pro-inflammatory or classically activated M1 macrophages are induced by TH1 cytokines like interferon γ (IFNγ) or interleukin 1β (IL-1β), alternatively activated M2 macrophages are triggered by TH2 cytokines such as IL-4 and IL-13. However, such activation profile has never been demonstrated in human skeletal muscles 34 . The sequential infiltration of pro-inflammatory and anti-inflammatory macrophages in mouse injured muscles shows their differential roles during muscle regeneration. Pro-inflammatory macrophages invade the injured areas shortly after damage to release a number of cytokines that stimulate myoblast proliferation. Anti-inflammatory macrophages are present locally at late stages of regeneration and act as promoters of myoblast differentiation and fusion 35 . While the regulation of myogenic lineage by macrophages is well characterized 36 , the control of FAP differentiation by macrophages is still not investigated in humans. Moreover, the recent study of interactions between mouse FAPs and macrophages has not clearly distinguished the impacts of different macrophage functional phenotypes on FAP fibro-adipogenesis 20 . Here we compare the influence of factors secreted by human healthy donor primary IL-1β-polarized macrophages (M (IL-1β)) or IL-4-induced macrophages (M(IL-4)) on the differentiation of FAPs derived from human skeletal muscle. This crosstalk between FAPs and macrophages uncovers a new mechanism regulating the intramuscular adipocyte deposits in human skeletal muscles.
Results
FAPs and macrophages closely located in human dystrophic muscles. DMD muscles are characterized by a significant inflammatory reaction with an increased number of infiltrating macrophages 37 and FAPs
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. Indeed, DMD muscles presented numerous CD140 + FAPs (Fig. 1A ) and macrophages expressing CD68 (Fig. 1B) , a surface marker expressed by all macrophage subtypes 38 . By contrast, healthy muscles displayed few CD140 + FAPs ( Supplementary Fig. S1A ) and CD68 + macrophages ( Supplementary Fig. S1B ). Interestingly, CD140 + FAPs (Fig. 1A ) and CD68
+ macrophages (Fig. 1B) were localized in the same regions where degenerating areas were observed, as represented by the presence of fibrillary collagen stained by SHG (second harmonic generation) in blue. To demonstrate a possible connection between FAPs and macrophages, DMD muscle sections were co-stained with anti-CD140a and anti-CD68 antibodies. Importantly, CD140
+ FAP and CD68 + macrophages were found in very close proximity in degenerating areas (Fig. 1C) . At the higher magnification, we observed that one CD68 + macrophage (white arrow) was in contact with FAPs (in green), whereas another CD68 + macrophages (red arrow) was located less than 20 µm from FAPs (Fig. 1C, right panel) . The number of CD68 + macrophages per section was approximately 12.4 ± 6.85 and the number of CD68 + macrophages in contact with FAPs per section was approximately 3 to 8 ± 0.10. This results show for the first time in humans and particularly in DMD muscles, that FAPs and macrophages resided near to each other, suggesting a potential in vivo interaction between these two types of cells.
Unlike fibrogenesis, adipocyte differentiation of human FAPs is affected by M(IL-1β) and M(IL-4) macrophage-secreted factors. Before evaluating the effect of macrophage-derived factors on human FAP differentiation, we firstly validated the in vitro model of human primary macrophage polarization as well as the adipogenic potential of FAPs. Three distinct conditioned media (CM) from control unpolarized resting macrophages (RM), IL-1β-treated (M(IL-1β)) or IL-4-treated (M(IL-4)) macrophages were produced. IL-1β, but not IL-4, increased the gene expression of IL1B, IL6 and CCL2 in macrophages ( Supplementary Fig. S2A ). IL-4, but not IL-1β, stimulated the gene expression of MRC1, CD200R1, F13A1 and CCL18 ( Supplementary Fig. S2B ) in macrophages. According to the nomenclature of macrophage activation and polarization 33 , these data indicate that M(IL-1β) and M(IL-4) can be considered as pro-inflammatory and anti-inflammatory macrophages, respectively. RM CM was used as control CM for unpolarized RM macrophages. We also confirmed the high adipogenic potential of FAPs as shown by the presence of adipocytes with lipid droplets (Supplementary Fig. S3A ) and the induction of adipocyte marker expression ( Supplementary Fig. S3B ) after 3, 8, 13, 17 and 20 days of differentiation in the presence of a pro-adipogenic medium.
To note, adipogenesis is conserved in FAPs isolated from skeletal muscles of DMD patients. Indeed, gene expression of adipogenic markers PLIN1, ADIPOQ and FABP4 was similar in DMD patients compared to healthy donors ( Supplementary Fig. S3C ). Then, confluent FAPs were induced to differentiate in a pro-adipogenic medium containing RM, M(IL-1β) or M(IL-4) CM (50/50), and adipogenic differentiation was measured 10 days later. Interestingly, CM from M(IL-1β) or M(IL-4) macrophages strongly affected FAP adipocyte differentiation compared to RM CM ( Fig. 2A, top and middle panels). Indeed, lipid accumulation, as stained by oil red O, was lower in the presence of CM from M(IL-1β) macrophages, compared to RM CM. By contrast, lipid accumulation increased after incubation with CM from M(IL-4) macrophages. In line, the number of FAPs committed into adipogenesis decreased in the presence of M(IL-1β) CM but strongly increased with CM from M(IL-4) macrophages (Fig. 2B) . Moreover, a smaller size was observed for adipocytes differentiated with M(IL-1β) CM whereas bigger adipocytes were detected in the presence of M(IL-4) CM, compared to RM CM (Fig. 2C ). This observation correlated with the lower number of lipid droplets/adipocyte observed with M(IL-1β) CM than with CM from M(IL-4) macrophages (Fig. 2D) . (Fig. 3C) .
The effect of M(IL-1β) and M(IL-4) CM on the inflammatory status of FAPs after 10 days of differentiation was also investigated by measuring the expression of pro-inflammatory markers (Fig. 3D) . Interestingly, only M(IL-1β) CM significantly induced IL6, C-X-C motif chemokine ligand 8 (CXCL8) and TNFA expression compared to RM or M(IL-4) CM. IL1B and C-C motif chemokine ligand 2 (CCL2) expression also tended to be more expressed in M(IL-1β) CM-treated FAPs but without reaching statistical significance. Finally, in line with the results of fibrogenesis ( Fig. 2A bottom panel) , expression of specific fibrogenic markers such as collagen 1 type A1 (COL1A1), fibronectin 1 (FN1) and α actin 2 (ACTA2) did not vary between the three experimental conditions (Fig. 3E) .
Therefore, M(IL-1β) macrophage-secreted factors inhibited adipogenesis and promoted the gene pro-inflammatory profile while M(IL-4) macrophage-secreted factors stimulated adipocyte differentiation of human FAPs.
Smad2 phosphorylation drives the reduced FAP adipogenesis by M(IL-1β) macrophages.
Since an anti-adipogenic role of recombinant TGFβ1 has been previously shown in FAPs 28 , the effect of SB431542, a specific inhibitor of the TGFβ superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 39 , was first examined on intrinsic FAP adipogenic differentiation. As expected, SB431542 stimulated FAP differentiation into adipocytes (Fig. 4A) , an effect correlated with a three fold increase of PLIN1 gene expression (Fig. 4B) . These data prompted us to hypothesize a potential role of the ALK signalling pathway in the inhibition of adipogenic differentiation of FAPs by M(IL-1β) macrophages. To verify this hypothesis, FAPs were differentiated in the presence of M(IL-1β) CM with or without SB431542 and the effect of the inhibitor on adipogenesis was evaluated 10 days later and was compared to M(IL-4) CM-treated FAPs. The addition of SB431542 counteracted the M(IL-1β) CM-dependent inhibition of FAP adipogenesis, as assessed by an increase of oil red O staining (Fig. 4C ) and the expression of several adipocyte markers (Fig. 4D ). Lipid accumulation, PLIN1 and ADIPOQ gene expression indicated that adipogenic rate in FAPs treated with M(IL-1β) CM and SB431542 was lower than in M(IL-4) CM-treated FAPs. By contrast, FABP4 and C/EBPA expression was higher. We concluded that activation of the ALK/Smad2 pathway by soluble molecules secreted by M(IL-1β) macrophages was required to inhibit FAP differentiation into adipocytes. We then measured the expression and phosphorylation of Smad2, a downstream effector of ALK. A lower Smad2 phosphorylation was observed in FAPs cultured with M(IL-4) CM, compared to M(IL-1β) CM-treated FAPs (Fig. 4E,F) . This indicates that the regulation of FAP adipogenesis by M(IL-1β) and M(IL-4) macrophages was associated with a differential activation of the ALK/Smad2 signalling pathway.
FAP localise closed to alternative macrophages in DMD muscles. Expression of mannose receptor C-type 1 (MRC1), that codes for the mannose receptor (MR), was strongly induced in macrophages by IL-4 but not by IL-1β (Supplementary Fig. 2B ). This receptor is considered as an in vivo marker for alternative macrophages 38 . We found the presence of MR + macrophages in DMD muscle sections (Fig. 5A ) and in healthy muscles ( Supplementary Fig. S4 ). Interestingly, MR + macrophages were located in the same fibrotic regions (Fig. 5A ) than CD140
+ FAPs (Fig. 1A) in DMD muscles. To assess a possible interaction between FAPs and MR + macrophages in vivo, DMD muscle sections were co-stained with human anti-CD140a and anti-MR antibodies. Importantly, MR-positive macrophages were located near to the CD140 + FAPs (Fig. 5B) . Indeed, at the higher magnification, we found one MR + macrophage (in red) in contact with FAPs (in green) (Fig. 5B, right panel) . The number of MR + macrophages per section was approximately 4.25 ± 1.73 and the number of MR + macrophages in contact with FAPs per section was approximately 1/2 ± 0.18. These data strongly suggest that in vivo M(IL-4) alternative macrophages could interact with FAPs to control their adipogenic potential.
Discussion
We have earlier reported that FAPs located between myofibers in human skeletal muscles can differentiate into white adipocytes in vitro and in vivo 28 . The regulation of their adipogenesis during muscle regeneration was partly characterized in mice. Indeed, satellite cell-derived myofibers strongly inhibit adipogenesis of FAPs to prevent fatty infiltration in regenerating muscles toward successful repair 19 . In addition to myogenic progenitors and FAPs, macrophages are central actors of regeneration in healthy and dystrophic muscles 40 . However, to our knowledge, no studies on the control of FAP differentiation by macrophages have been performed in humans. Here, we report that IL-1β-activated macrophages and IL-4-polarized macrophages have opposite effects on FAP differentiation into adipocytes in vitro, and this was dependent on the Smad2 phosphorylation status in FAPs.
First, we show that CD140 + FAPs localized closed to CD68 + macrophages in DMD muscles, thus strengthening our hypothesis that macrophages could regulate FAPs behavior in humans. To verify this hypothesis, we used an experimental model where human FAPs were differentiated in the presence of conditioned medium from human blood monocyte-derived macrophages. Monocytes were differentiated for 6 days into unpolarized (RM) macrophages or were polarized into anti-inflammatory macrophages with IL-4 (M (IL-4) ) or into pro-inflammatory macrophages with IL-1β (M (IL-1β) ). The choice of these stimuli is consistent with the high IL1-β expression in the diaphragm of mdx mice 41 , an animal model to study DMD, and with the expression of IL-4 receptor by macrophages in quadriceps of these mice 42 . These results thus validate the pertinence of our in vitro model of macrophage polarization. We use CM from resting macrophages as control to assess the effect of macrophage inflammatory status on FAP differentiation and to get rid of the decrease in medium nutrients in M(IL-1β) and M(IL-4) CM.
Importantly, we demonstrated that factors released from M(IL-1β) macrophages inhibit the differentiation capacity of FAPs while M(IL-4) macrophage-secreted molecules have a pro-adipogenic effect. CM affect both the differentiation of FAPs into adipocytes, as indicated by the variation of adipocyte number, and the terminal adipogenesis of FAPs, as shown by the modulation of adipocyte size and the number of lipid droplets per adipocyte. We can hypothesize that the M(IL-4)-dependent increase of adipocyte number can be explained by an enhancement of FAP commitment towards the adipogenic lineage. Interestingly, C/EBPB, a master gene of adipocyte commitment 43 , was unaffected, suggesting that macrophages regulate events downstream to C/EBPB expression. In the last decade, several studies reported that human macrophage cell lines or primary monocyte-derived pro-inflammatory macrophages inhibit adipogenesis of adipose progenitors derived from human adipose tissue [44] [45] [46] [47] . Similar to these results, gene expression of PPARG and C/EBPA, the two master regulators of adipocyte differentiation 43 , decreased in FAPs cultured with M(IL-1β) CM. By contrast, since C/EBPB expression was unaffected, this suggests that this transcription factor is not required for the effect of macrophages on PPARG and C/ EBPA gene expression at day 10 of differentiation. This was consistent with the reported anti-adipogenic effects of secreted factors from bacterial lipopolysaccharide (LPS)-activated human monocyte-derived macrophages on subcutaneous adipose tissue preadipocytes 47 . Conversely to Lacasa et al., leptin expression did not vary in our experiments in FAPs cultured with M(IL-1β) conditioned medium, suggesting a specificity of FAP-derived adipocytes. We had also shown that these adipocytes have the unexpected feature of being insulin-resistant 28 . It was reported that M(IL-4) anti-inflammatory macrophages serve as an important source of catecholamine for beiging activation in mouse subcutaneous adipose tissue [48] [49] [50] [51] . However, no expression of uncoupling protein 1 (UCP1), a marker of adipocyte beiging, was detected in human FAPs cultured with M(IL-4) conditioned medium (data not shown), suggesting that factors released by M(IL-4) macrophages stimulated the differentiation of FAPs into white adipocytes exclusively. This is in accordance with our previous work showing that human FAPs give rise to bona fide white adipocytes 28 . We also found that anti-adipogenic effect of M(IL-1β) macrophages is associated with the increase of IL-6, IL-8, TNFA, IL-1B and MCP-1 gene expression in FAPs after 10 days of culture in pro-adipogenic medium. Even if these results have to be confirmed at the protein level, the significance increase of pro-inflammatory cytokines in FAPs cultured with M(IL-1β) CM and their defective engagement toward adipogenesis needs to be understood, particularly during the muscle regeneration process and in DMD muscles characterized by macrophage infiltration in injured areas. Previous studies have reported that IL-6, MCP-1, TNFα and IL-1β are usually up-regulated in damaged muscle in the early phase of regeneration 52, 53 and in dystrophic muscles [54] [55] [56] where an intramuscular accumulation of FAPs is observed. FAPs could be one of the sources of these cytokines in injured and diseased muscles and, thus, could mediate the inflammatory response. In addition to their role in inflammation, IL-6 and TNFα can also contribute to muscle homeostasis by controlling the proliferative and differentiation capacities of muscle stem cells 52, 57 . Interestingly, mouse FAPs provide a source of IL-6 that regulate satellite cell activity 58 . In addition to their adipogenic potential, in vitro human FAPs display fibrogenic capacity in response to TGFβ1 27, 28 . We showed that M(IL-1β) and M(IL-4) macrophage-secreted factors did not affect extra-cellular matrix. In contrary to our results, it has been reported that inflammatory adipose tissue-derived preadipocytes exposed to macrophage-secreted factors overexpressed extra-cellular matrix genes 45, 59, 60 . This discrepancy could be explained by the different cytokines secreted by macrophages employed in each study, which differ in their origin (isolated from blood 45, 59 or adipose tissue 60 ), and in their culture conditions (such as difference in stimuli used to induce differentiation). Moreover, our results were obtained in a pro-adipogenic medium, which is not representative of the environment of fibrotic muscles, such as DMD. Further experiments using for example a pro-fibrogenic medium complemented with TGFβ1, could allow concluding regarding a potential regulation of FAP fibrogenesis by macrophages. Mechanistically, we show that M(IL-1β) macrophages-secreted factors highly phosphorylated Smad2 in FAPs, and this phosphorylation is mediated by ALK4/5/7 receptor activity. Human DMD muscles contain CD140a-expressing cells that are positive for phospho-Smad2/3 61 , but are also invaded by adipocytes. These conflicting results could be explained by the difference in the inflammatory status between in vitro and in vivo macrophages. Members of the TGFβ family, that are known to stimulate Smad2 phosphorylation via ALK4/5/7 receptor activity, are numerous such as activins, myostatine, GDF11 (growth differentiation factor 11) and TGFβs 62 . Their implication in the inhibition of FAP adipogenesis by M(IL-1β) macrophages remains to be identified. Finally, we detected FAPs in proximity to MR-positive macrophages in human DMD muscles suggesting that these macrophages could promote the accumulation of intramuscular adipocytes by interacting with FAPs. Furthermore, healthy and DMD FAPs have similar adipogenic differentiation rate suggesting that DMD FAPs could be competent to respond to signals issued from MR-positive macrophages.
In summary, our results show that M(IL-1β) macrophages release cytokines that inhibit FAP adipogenesis via Smad2 phosphorylation, whereas M(IL-4) macrophages have a pro-adipogenic effect. These differential interplays between FAPs and macrophage subtypes provide new elements to help developing medical regenerative strategies to prevent adipocyte deposits in diseased muscles associated with a chronic inflammation such as DMD.
Materials and Methods
Reagents and antibodies. Cell culture media, serum, phosphate-buffered saline and trypsin were purchased from Lonza (Verviers, Belgium) and cell culture reagents were from Sigma-Aldrich Chimie (SaintQuentin Fallavier, France).
Human antibodies for immunofluorescence analysis were purchased as indicated: anti-αSMA (#A5228) from Sigma-Aldrich, anti-CD68 (#EBM11) from Dako (Glostrup, Denmark), anti-MR (#ab8918) from Abcam (Cambridge, United-Kingdom), anti-CD140a (#3174 T) from Cell Signaling (Ozyme, St Quentin en Yvelines, France). Human antibodies for western blot analysis were purchased as indicated: anti-phospho-Smad2 (Ser465/467, #3101) and anti-Smad2/3 (#3102) from Cell Signaling, and anti-β-tubulin from Sigma-Aldrich. Human antibodies against CD56-APC (#341027) and CD140a-PE (#556002) were purchased from BD-Biosciences (Le Pont de Claix, France). Human recombinant IL-4 (#200-04) and IL-1β (#200-01B) were purchased from Peprotech (Neuilly-Sur-Seine, France) and used at 15 ng/ml. SB431542 (#S4317) was purchased from Sigma-Aldrich Chimie and used at 5 µM. DRAQ5 fluorescent probe (#62254) was purchased from Thermofisher Scientific and used at 20 µM.
Human skeletal muscle FAP isolation. Tissue samples were obtained as res nullius from surgeries or diagnostic biopsies from healthy donors aged from 1 to 8 years and with the informed consent of the parents. All protocols for healthy skeletal muscles were approved by the Centre Hospitalier Universitaire de Nice Review Board, according to the French Regulatory Health Authorities. Samples were placed in F10 medium and transferred to the laboratory. DMD biopsies were obtained from Myobank-AFM Institut de Myologie, Paris, France. Characteristics of healthy and DMD muscles are reported in Table 1 . Skeletal muscle cells were isolated by a standard method 28 . Briefly, healthy skeletal muscles were minced into 1 mm 3 fragments and digested at 37 °C, first using liberase (Roche Diagnostics, Meylan, France) for 1 hour and then using 0.25% trypsin-EDTA (Lonza, Verviers, Belgium) for 20 minutes. The enzymatic reaction was stopped by adding 10% fetal bovine serum (FBS). The suspension was homogenized, cells pelleted by centrifugation and cultured in growth culture medium (Ham's F10 medium supplemented with 20% FBS, 10 mM Hepes, 10 −6 M dexamethasone, 2.5 ng/ml basic fibroblast growth factor, 100 U/ml penicillin, and 100 mg/ml streptomycin).
FAP purification was performed as previously described Human peripheral blood mononuclear cell isolation and culture. Blood mononuclear cells were isolated from healthy donors (French Blood Service, Marseille, France). After Ficoll gradient centrifugation, the monocytes were suspended in RPMI 1640 medium (Gibco, Thermofisher Scientific) containing 0.1 mg/mL gentamycin, 2 mM glutamine and 10% decomplemented human serum. Cells were cultured at a density of 10 × 10 FAP and macrophage indirect co-cultures. FAP cells were seeded in 12 well-plastic culture dishes at a density of 1 × 10 5 cells/well in the growth medium. Two days later, adipogenic differentiation was induced on confluent FAPs by switching the growth medium to a pro-adipogenic differentiation medium (Ham's F10/ F12/low-glucose DMEM with 2 mM glutamine (2 v/1 v/1 v), 2% horse serum, 1 mM dexamethasone, 100 µM 1-methyl-3-isobutylmethyl-xanthine (MIX), 15 µg/ml insulin, 15 µg/ml transferrin, 0.2 nM triiodothyronine, and 100 nM rosiglitazone) containing RM, M(IL-1β) or M(IL-4) CM (at the ratio of 50/50). Three days later, cells were placed in the same medium lacking MIX and dexamethasone but still containing CM at the ratio 50/50. This differentiation medium was replaced every 3 days and cells were collected after 10 days of differentiation.
Oil red O staining and adipocyte morphometry analyses. Differentiated adipocytes were PBS-washed, fixed in 4% paraformaldehyde for 10 min, and treated for 30 min with oil red O (60% of a stock solution at 0.5% w/v in isopropanol and 40% distilled water). Cells were washed with isopropanol/water (6 volumes/1 volume) to remove the unspecific staining and then several times with water. Images were recorded with a TE-2000U bright-field optical microscope (Nikon, Tokyo, Japan). Lipid droplet areas were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD, USA). The number of adipocytes per field was counted on at least 15 different fields. The number of lipid droplets was counted per adipocyte. Incomplete droplets located at the edge of the image were excluded. At least 30 adipocytes from each condition were measured. 
RNA extraction and Reverse Transcription quantitative polymerase chain reaction (Q-PCR).
Total RNA was extracted using TRI-reagent (Euromedex, Souffelweyersheim, France). Methods of RNA extraction and quantitative Q-PCR were previously described 28 . TATA box-binding protein (TBP) was used as housekeeping gene. The sequences of primers used are listed in Table 2 .
Western blot analysis. Cells were lysed in RIPA buffer consisting of 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 5 mM NaF, 2.5 mM Na 4 P 2 O 7 , 1% NP40, 2 mM sodium vanadate and protease inhibitor cocktail (Roche Diagnostics, Meylan, France). Cell lysates were centrifuged at 13 000 g for 10 minutes at 4 °C, the supernatants were recovered and the protein content determined (Pierce BCA Protein Assay Kit, Thermoscientific, Rockford, IL, USA; #23227). 10 µg of proteins were resolved by 7.5% SDS-PAGE under reducing conditions and transferred to Immobilon-P membranes (Millipore Corporation, Bedford, MA, USA). The membranes were probed with primary antibodies that were detected by horseradish peroxidase-conjugated secondary antibodies (Promega, Charbonnières-les-bains, France) and visualized with an electrochemical luminescence detection kit (Bio-Rad, Marnes-la-Coquette, France). Band intensities were measured by the Quantity One software (Bio-Rad).
Statistical analysis. Statistical differences between groups were evaluated using the two-tailed unpaired Student's t-test. A P-value < 0.05 was considered as significant.
